Heh. The radical results are probably only unique to her and an occasional other patient. The commercially viable and statistically derived average or generic person is what the pharmaceutical industry and the vetting slash safety establishment are restricted to accommodating. Not freak outliers.[1] For instance, there's a venomous snake-bite treatment that worked twice "only" for me (the latter a justified conclusion based on it being one of the very approaches that medical experts warn victims not to engage in, due to it increasing the severity for most people rather than remedying it).
[1] Excluding rare conditions one might be born with, etc, that incredibly expensive drugs are developed especially for, with regard to that tiny minority.
- - - - - - - - - - - - - -
Huge psilocybin dose has incredible effect on elderly dementia patient
https://www.sciencealert.com/huge-psilocybin-dose-has-incredible-effect-on-elderly-dementia-patient
EXCERPT: The elderly woman with dementia was first treated with an incredibly high dose of 5 grams of psilocybin-containing mushrooms, which caused her to enter a prolonged, deep sleep-like state. Before the experimental treatment, the patient could only speak in monosyllables, rarely initiated communication with others, and was very dependent on assistance for basic activities of daily living.
Roughly 19 hours after the oral dose, the woman suddenly began to talk to herself. She kept doing so for several hours. Over the next few days, the elderly patient was reportedly able to control her bladder, dress and walk by herself, and engage in conversation, holding eye contact and smiling back. (MORE - details)
_
[1] Excluding rare conditions one might be born with, etc, that incredibly expensive drugs are developed especially for, with regard to that tiny minority.
- - - - - - - - - - - - - -
Huge psilocybin dose has incredible effect on elderly dementia patient
https://www.sciencealert.com/huge-psilocybin-dose-has-incredible-effect-on-elderly-dementia-patient
EXCERPT: The elderly woman with dementia was first treated with an incredibly high dose of 5 grams of psilocybin-containing mushrooms, which caused her to enter a prolonged, deep sleep-like state. Before the experimental treatment, the patient could only speak in monosyllables, rarely initiated communication with others, and was very dependent on assistance for basic activities of daily living.
Roughly 19 hours after the oral dose, the woman suddenly began to talk to herself. She kept doing so for several hours. Over the next few days, the elderly patient was reportedly able to control her bladder, dress and walk by herself, and engage in conversation, holding eye contact and smiling back. (MORE - details)
_
Last edited: